Another preclinical study using subcutaneous xenograft and peritoneal metastasis models of GC investigated the therapeutic potential of HER2 CAR-T cells expressing a humanized chA21 ScFv and the co-stimulatory domain 4-1BBz [80]. The gene discussed is ERBB2; the disease is gastric cancer.